Goldman Sachs lowered the firm’s price target on Mirion (MIR) to $28 from $29 and keeps a Buy rating on the shares as part of a broader research note previewing Q1 results among multi-industry names. The firm is updating its segment level estimates and bakes in a lower interest rate for 2026 and the out years, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MIR:
- Mirion price target lowered to $26 from $29 at Baird
- Mirion price target lowered to $27 from $30 at JPMorgan
- Mirion price target lowered to $27 from $29 at Morgan Stanley
- Mirion price target lowered to $30 from $33 at JPMorgan
- Mirion Technologies: Solid Nuclear and Medical Demand, Improving Margins, and Paragon Synergies Support Buy Rating and Mid-30% Upside Potential